THOMAS JAMES DOYLE - 27 Sep 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role: SVP, Finance & Accounting
Signature: /s/ Thomas Doyle
Issuer symbol: KURA
Transactions as of: 27 Sep 2025
Net transactions value: -$40,607
Form type: 4
Filing time: 29 Sep 2025, 19:30:02 UTC
Previous filing: 28 Jan 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
DOYLE THOMAS JAMES	SVP, Finance & Accounting	C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO	/s/ Thomas Doyle	29 Sep 2025	0001910331

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KURA	Common Stock	Award	$0	+24,966	+28%	$0.000000	114,370	27 Sep 2025	Direct	F1
transaction	KURA	Common Stock	Sale	$40,607	-4,541	-4%	$8.94	109,829	29 Sep 2025	Direct	F2
holding	KURA	Common Stock						500	27 Sep 2025	spouse's 401(k)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.
F2	Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

Content

Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.